Insurance questions can feel as stressful as the shoulder pain itself. This guide explains how health plans generally decide whether to pay for a newer procedure like shoulder embolization, what published insurer policies say about joint embolization, and the steps that help you avoid a surprise bill. It cannot tell you what your own plan will do. Only your plan, and a benefits check by the office, can answer that.

The short answer
Coverage for shoulder embolization is uncertain and varies by plan. Very few insurers have published a policy written specifically about the shoulder. Insurers that have written policies on joint embolization, which so far mostly address the knee, have generally classified it as investigational or not medically necessary. Because the shoulder has less research behind it than the knee, you should assume coverage is not automatic and confirm the details with your plan before treatment.
How insurers decide what to cover
Most health plans publish medical policies (sometimes called coverage policies or clinical policy bulletins) that spell out when a procedure is considered medically necessary. When a treatment is new, plans often label it one of the following:
- Investigational or experimental: the plan believes the evidence is not yet strong enough, so it usually will not pay
- Unproven: a similar label used by some plans
- Not medically necessary: the plan does not consider the service required for your condition
- Medically necessary with criteria: the plan will pay if you meet specific conditions
Plans weigh randomized controlled trials heavily. As of October 2026, shoulder embolization research consists mainly of single-arm studies without comparison groups, and randomized trials are still recruiting. That is the main reason coverage is limited. You can read more in shoulder embolization research and success rates.
What published policies say about joint embolization
We reviewed publicly available policies in October 2026. Here is what we found:
- Carelon Medical Benefits Management, which reviews procedures for many Anthem and Elevance Health plans, updated its vascular embolization guideline effective November 15, 2026. It states that genicular artery embolization (knee) "is considered not medically necessary." The guideline does not address shoulder embolization.
- Blue Cross Blue Shield of Texas lists knee embolization as "experimental, investigational and/or unproven" for knee pain in a 2025 policy.
- UnitedHealthcare announced in September 2026 that, starting December 1, 2026, it will require prior authorization for therapeutic vascular embolization procedures billed under a common embolization code on its commercial, Medicare Advantage, and most Community Plans. The announcement focused on other uses of embolization and did not specifically address joint pain.
- We did not find a published policy dedicated to shoulder embolization from Aetna, Cigna, UnitedHealthcare, or Anthem.
Why mention knee policies in an article about the shoulder? Knee embolization has the most research of any joint embolization, including randomized sham-controlled trials. If insurers are still cautious about the knee, it is reasonable to expect them to be at least as cautious about the shoulder.
Policies change often. A policy that is silent on the shoulder does not mean the procedure is covered. Plans frequently apply general rules about investigational services to anything without its own policy.
Prior authorization: why it matters
Prior authorization is advance approval from your plan. For a procedure like shoulder embolization, getting a written decision before treatment is one of the best ways to avoid a surprise. A typical request includes:
- Your diagnosis and how long you have had symptoms
- A record of the treatments you have already tried, such as physical therapy, medication, and injections, and how you responded
- Imaging results
- The procedure codes the office plans to bill
- A letter from your doctor explaining why the procedure is appropriate for you
If your plan says no, the denial letter should explain why and how to appeal.
Questions about your treatment options? Dr. Fox can help.
Book a ConsultationThis article is part of our Embolization Guide.
If coverage is denied
A denial is not always the final word. Options include:
- An internal appeal. Your doctor can submit more information, such as published studies and details of your failed treatments.
- A peer-to-peer review. Your doctor speaks directly with the plan's medical reviewer.
- An external review. If internal appeals fail, many plans allow review by an independent organization. Your denial letter should explain this right.
- Self-pay. Some patients choose to pay directly. If you go this route, ask for a written estimate that covers the physician fee, facility fee, imaging, and follow-up visits, so nothing is left out.
Appeals for treatments labeled investigational are often difficult, so it is wise to plan for the possibility that you will be responsible for the cost.
Understanding what goes into the bill
Even when the procedure itself is not covered, several separate charges can be involved, and each may be treated differently by your plan:
- The consultation visit. An evaluation of shoulder pain is a standard office visit and is often billed like any specialist visit.
- Imaging. X-rays or an MRI ordered to diagnose your shoulder problem may be covered under your regular benefits, even if embolization is not.
- The physician's procedure fee. This covers the embolization itself.
- The facility fee. Where the procedure is done, such as an office-based lab, outpatient center, or hospital, can change both the cost and the coverage rules.
- Sedation and supplies. These may be billed separately.
- Follow-up visits and physical therapy. These are usually billed on their own.
Asking about each of these separately helps you build a realistic picture before you decide.
What the office can do for you
Before treatment, the office can typically verify your benefits, explain which codes are involved, submit prior authorization when your plan requires it, and tell you in writing what you may owe. Bring your insurance card and a list of previous shoulder treatments to your visit. Our consultation guide includes a checklist, and the practice's general insurance coverage guide covers how billing works for other procedures.
Questions to ask your insurance company
- Do you have a medical policy on transcatheter arterial embolization for shoulder or joint pain? Can you send me a copy?
- Is prior authorization required for the procedure codes my doctor plans to use?
- Is the procedure considered investigational under my plan?
- If it is not covered, will the related visits, imaging, or facility charges also be denied?
- What is my out-of-network benefit, if the doctor is out of network?
- How do I file an appeal, and what is the deadline?
Write down the date, the representative's name, and a reference number for every call.
Treatments that are more often covered
Standard frozen shoulder care, such as physical therapy, steroid injections, and in some cases hydrodilatation or surgery, is more established and generally more likely to be covered, subject to your plan's rules. Many plans expect you to have tried these first, which also matches how shoulder embolization was studied. To learn more about the procedure itself, see our shoulder embolization page or the embolization guide.
Frequently Asked Questions
Does insurance cover shoulder embolization?
It depends on your plan, and coverage is often limited. Insurers that have written policies on joint embolization have mostly classified it as investigational or not medically necessary, so check with your plan and get a written decision first.
Does Medicare cover shoulder embolization?
We could not find a Medicare policy specific to shoulder embolization. Coverage decisions may vary by region and plan type, so ask the office to verify your Medicare or Medicare Advantage benefits before treatment.
Will the office check my coverage before the procedure?
The office typically verifies benefits and, when required, submits prior authorization before treatment so you know what to expect.
Why do insurers call it investigational?
Insurers rely heavily on randomized controlled trials. Shoulder embolization studies so far have been mostly single-arm studies without a comparison group.
Keep Reading
- Shoulder Embolization in Manhattan
- Is Shoulder Embolization Painful? What to Expect Before, During, and After
- Your Shoulder Embolization Consultation Guide
- Shoulder Embolization Recovery Timeline: Week by Week
- Shoulder Embolization Research and Success Rates: An Honest Review
- Shoulder Embolization Risks and Side Effects: What Studies Show
- Embolization Guide: knee, heel, shoulder, elbow and hip
Sources
- Carelon Medical Benefits Management — Vascular Embolization and Occlusion Procedures guideline, effective 11/15/2026
- Blue Cross Blue Shield of Texas — Medical Policy SUR705.048, Genicular Artery Embolization (2025)
- UnitedHealthcare Provider News, Sept 2026 — new therapeutic vascular embolization policy and prior authorization
- Allaw et al., J Vasc Interv Radiol, 2026 — systematic review and meta-analysis of embolization for adhesive capsulitis (12 studies, 329 shoulders)
- ClinicalTrials.gov NCT06095050 — embolization vs physical therapy for chronic shoulder tendinopathy (recruiting)
- ClinicalTrials.gov NCT07336849 — embolization vs usual care for chronic shoulder pain (recruiting)
- ClinicalTrials.gov NCT07696923 — embolization vs corticosteroid injection for frozen shoulder (recruiting)
Medically reviewed by David Fox, MD, FACS, RPVI. This article is general information, not a substitute for a medical evaluation.
Living with joint or tendon pain that hasn’t improved? Schedule a consultation with Dr. David Fox at Fox Vein & Vascular in Manhattan to find out whether embolization is right for you. Call (212) 362-3470 or request an appointment online.

